Background: Bariatric surgery is a cornerstone intervention for individuals with severe obesity, offering substantial and sustainable weight loss.
Methods: This retrospective cohort study included 186 patients with obesity and Type2 diabetes who underwent sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) between 2009 and 2020 at University Hospital Ayr. Optimal clinical response weight loss was defined as excess weight loss (%EWL) ≥50 % or total weight loss (%TWL) ≥20 %.
Results: At 2-years post-surgery, 43.6 % achieved ≥50 %EWL, and 44.1 % achieved ≥20%TWL, with 31.8 % maintaining this at 5-years. Depending on the definition used, between 11.2 % and 45.9 % of patients experienced recurrent weight gain. BMI had significant positive association with %TWL but negative with %EWL (p < 0.05). RYGB had significantly higher %TWL compared to SG (p < 0.05).
Conclusion: Most patients experienced weight loss which was maintained over time, however recurrent weight gain was noted. Pre-surgery BMI was significantly associated with weight changes.
Keywords: Bariatric surgery; Excess weight loss; Gastric bypass; Sleeve gastrectomy; Total weight loss.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.